HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Purchase Article View Shopping Cart Alert me when this article is cited Alert me if a correction is posted Citation Map Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Fisker, A. B Articles by Benn, C. S Search for Related Content PubMed PubMed Citation Articles by Fisker, A. B Articles by Benn, C. S Agricola Articles by Fisker, A. B Articles by Benn, C. S

Effect of vitamin A supplementation with BCG vaccine at birth on vitamin A status at 6 wk and 4 mo of age ^1,2,3

¹ From the Bandim Health Project, INDEPTH Network, Bissau, Guinea-Bissau (ABF, AR, and PA); the Bandim Health Project, Statens Serum Institut, Copenhagen, Denmark (PA and CSB); the Department of Infectious Diseases, Aarhus University Hospital, Aarhus, Denmark (ABF); the Department of Pathology, Herlev University Hospital, Copenhagen, Denmark (IML); the Department of Biostatistics, University of Aarhus, Aarhus, Denmark (BMB); and SEAMEO, Regional Center for Community Nutrition, University of Indonesia, Jakarta, Indonesia (JGE)

Background: The effect of vitamin A supplementation (VAS) at birth on subsequent vitamin A status has not been studied.

Objective: The objective was to study the effect of 50 000 IU vitamin A administered with BCG vaccine at birth on vitamin A status in both sexes.

Design: Within a randomized placebo-controlled trial of VAS, we obtained blood from 614 children at 6 wk of age and from 369 mother-infant pairs at 4 mo of age. We assessed vitamin A status on the basis of serum retinol-binding protein (RBP) and measured serum C-reactive protein to monitor for concurrent infections.

Results: RBP concentrations indicated vitamin A deficiency in 32% of the children at age 6 wk and in 16% at age 4 mo. VAS was not associated with higher RBP concentrations overall or in either sex. However, the effect of VAS varied with maternal education (P for interaction = 0.004): At age 6 wk, VAS was associated with higher (9%; 95% CI: 2, 17%) RBP concentrations in children of noneducated mothers but not in children of educated mothers. Overall, RBP concentrations increased between 6 wk and 4 mo of age. The increase correlated inversely with the number of diphtheria-tetanus-pertussis (DTP) vaccines received in the interval (P = 0.009), particularly in girls (P for interaction = 0.01) and in vitamin A recipients (P = 0.01).

Conclusions: Overall, VAS at birth had no effect on vitamin A status. However VAS may temporarily improve vitamin A status in the subgroup of children of noneducated mothers. In vitamin A recipients, subsequent DTP vaccines affected vitamin A status negatively. The main trial was registered at clinicaltrials.gov as NCT00168597.

Key Words: Vitamin A supplementation • BCG vaccine • retinol-binding-protein • acute phase reaction • sex differences • diphtheria-tetanus-pertussis vaccine

This article has been cited by other articles:

				S. A. Abrams and D. C. Hilmers Postnatal Vitamin A Supplementation in Developing Countries: An Intervention Whose Time Has Come? Pediatrics, July 1, 2008; 122(1): 180 - 181. [Full Text] [PDF]

				C. S. Benn, B. R. Diness, A. Roth, E. Nante, A. B. Fisker, I. M. Lisse, M. Yazdanbakhsh, H. Whittle, A. Rodrigues, and P. Aaby Effect of 50 000 IU vitamin A given with BCG vaccine on mortality in infants in Guinea-Bissau: randomised placebo controlled trial BMJ, June 21, 2008; 336(7658): 1416 - 1420. [Abstract] [Full Text] [PDF]